Optogenetics market seen hitting $81.05B by 2030

The Business Research Company projects the optogenetics market will grow from $47.13 billion in 2026 to $81.05 billion by 2030, a 14.5% CAGR. The forecast points to rising neuroscience funding, expanding disease research and wider use of optical and genetic tools across labs and translational studies.

Why it matters: - The optogenetics market is forecast to keep expanding fast as researchers use light and genetic engineering to study and control neural activity. - The technology has applications in disease research tied to Parkinson’s disease, memory impairments, anxiety, addiction and mood disorders. - Growth in this market signals more spending on neuroscience tools, data analysis and precision neuromodulation.

What happened: - The Business Research Company said the optogenetics market was worth $40.9 billion in 2025 and will reach $47.13 billion in 2026. - The company projected the market will rise to $81.05 billion by 2030, implying a 14.5% CAGR. - The report was released Aug. 20, 2026, in London. - North America held the largest share of the optogenetics market in 2025.

The details: - The report links near-term growth to breakthroughs in genetic engineering tools, higher neuroscience funding, broader use of optical stimulation methods, expanding academic and laboratory research, and better optical sensor capabilities. - Longer-term growth is expected to come from disease research, brain-focused investment, translational neuroscience studies, AI-driven data analysis and advances in optical actuator technologies. - The report says emerging trends include light-based neural control, genetically encoded optical sensors, and more research on neural circuits and precision neuromodulation. - Optogenetics uses optical systems and genetic engineering to control and observe biological processes at the cellular, tissue or organ level with high timing and spatial accuracy. - The field is especially useful for monitoring and regulating neuronal activity and other cell types involving light-sensitive proteins. - The report said US National Institutes of Health neuroscience research funding reached about $11.3 billion in fiscal year 2022 and was expected to rise to $12.1 billion in 2023. - The market analysis also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - The company offered a free sample report and a full report through the sample request page and the market report page.

Between the lines: - The forecast suggests optogenetics is moving from a niche research tool toward a broader platform for neuroscience and translational medicine. - The combination of AI analysis and genetically encoded sensors points to a market that is becoming more data-intensive as well as more precise. - North America’s lead likely reflects stronger research funding and deeper adoption across academic and laboratory settings.

What's next: - The market’s next phase will hinge on whether funding, sensor performance and optical actuator advances continue to improve at the same pace. - Adoption should expand if more disease research turns optogenetics into a standard tool for neural circuit studies and precision neuromodulation. - The Business Research Company is promoting the report and related forecasting materials to buyers and research teams.

The bottom line: - Optogenetics is on track for sustained double-digit growth through 2030, driven by neuroscience spending, technical progress and broader research use.